To assess the canonical downstream effector of NLRP3 inflammasome activation, we quantified the pro-inflammatory cytokine IL1β by Western blot in retinal homogenates from AD patients and normal-cognition controls. The gene discussed is NLRP3; the disease is Alzheimer disease.